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FluorescenceDaptomycin is a clinically important lipopeptide antibiotic that kills Gram-positive bacteria through mem-
brane depolarization. Its activity requires calcium and the presence of phosphatidylglycerol in the target
membrane. Calcium and phosphatidylglycerol also promote the formation of daptomycin oligomers, which
have been assumed but not proven to be required for the bactericidal effect. Daptomycin shares substantial
structural similarity with another lipopeptide antibiotic, A54145; the two have identical amino acid residues
in 5 out of 13 positions and similar ones in 4 more positions. We here examined whether these conserved
residues are sufﬁcient for oligomer formation. To this end, we used ﬂuorescence energy transfer and excimer
ﬂuorescence to detect hybrid oligomers of daptomycin and CB-182,462, a semisynthetic derivative of
A54145. Mixtures of the two compounds indeed produced hybrid oligomers, but at the same time displayed
a signiﬁcantly less than additive antibacterial activity against Bacillus subtilis. The existence of functionally
impaired oligomers indicates that oligomer formation is indeed important for antibacterial function. Howev-
er, it also shows that oligomerization is not sufﬁcient; once formed, the oligomers must take another step in
order to acquire antibacterial activity. Thus, the amino acid residues shared between daptomycin and
CB-182,462 sufﬁce for formation of the oligomer, but not for its subsequent activation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The lipopeptide antibiotic daptomycin is used clinically against
infections by Gram-positive bacteria, including strains of staphylococ-
ci and enterococci that are resistant to other antibiotics [1–3]. It binds
to and causes depolarization of the bacterial cytoplasmic membrane,
which is considered to be the mechanism of its rapid bactericidal
action [4,5]. Electron microscopy of daptomycin-exposed cells does
not reveal any discontinuity of the lipid bilayer [6]. Both this observa-
tion and the selective nature of the membrane permeability defect [7]
support the notion that daptomycin forms small, discrete membrane
lesions. It was proposed earlier that these discrete lesions are formed
by oligomeric assemblies of daptomycin molecules [5]. However,
experimental evidence of oligomer formation has been obtained
only recently [8,9], and direct proof of their involvement in mem-
brane permeabilization is still lacking.
Daptomycin consists of 13 amino acids, including several nonstan-
dard ones [10]. The ten C-terminal residues form a ring that is closed.
l rights reserved.by an ester bond (Fig. 1). The exocyclic N-terminal tryptophan carries
a fatty acyl residue, which in the clinical drug preparation is decanoic
acid, although the length of this acyl tail is subject to variation in the
natural product. The same architecture occurs in the related antibiotic
A54145 [11], and the two molecules also share signiﬁcant sequence
homology, with ﬁve identical residues and four more similar ones.
We reasoned that testing the two molecules for their ability to form
hybrid oligomers should provide information on the contributions
of the conserved and the non-conserved residues, respectively, to
the oligomerization process.
The experiments were performed with various ﬂuorescent deriva-
tives of daptomycin and of CB-182,462, a semisynthetic derivative of
A54145 [12]. Our results readily demonstrate the formation of such hy-
brid oligomers, both onmodel membranes and on bacterial cells; there-
fore, the amino acid residues conserved between daptomycin and
CB-182,462 are sufﬁcient for oligomerization. Remarkably, however,
the hybrid oligomers exhibit reduced antibacterial activity. The obser-
vation of oligomers with impaired antibacterial activity shows, on the
one hand, that the oligomer is indeed involved in the antibacterial
effect. On the other hand, it indicates that oligomer formation as such







































Fig. 1. Structures of daptomycin and of CB-182,462 and of their labeled derivatives used in this study. Arrows indicate amide or ester bonds, in C to N or C to O direction. In
perylene-daptomycin, a perylene-butanoyl residue replaces the N-terminally attached decanoyl residue found in daptomycin. CB-182,462 is a semisynthetic derivative of the
natural compound A54145, in which the naturally occurring N-terminally linked fatty acyl residue is replaced by a substituted carbamyl residue. In NBD-CB-182,462, a
nitrobenzoxadiazole group is attached to the free amine in the side chain of D-lysine. Abbreviated names for non-standard amino acids: Orn, ornithine; MeOGlu,
γ-methoxy-glutamate; kyn, kynurenine; HO-Asn, β-hydroxy-asparagine; MeOAsp, β-methoxy-aspartate. The two residues whose intrinsic ﬂuorescence was used in some of the
experiments, tryptophan in CB-182,462 and kynurenine in daptomycin, are set in boldface. Note that, in addition to the sequence similarity, the same positions are occupied by
D- and L-amino acids in both molecules.
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insertion or the adoption of a very speciﬁc structure, in order to acquire
bactericidal activity.
2. Materials and methods
2.1. Synthesis and puriﬁcation of NBD-CB-182,462 and of
perylene-daptomycin
Unlabeled CB-182,462 was provided by Cubist Pharmaceuticals
Inc. (Lexington, MA, USA). Reaction of CB-182,462 with NBD-Cl
(4-Chloro,7-nitro-2,1,3-benzoxadiazole; Fluka) and HPLC puriﬁcation
were performed as described before for NBD-daptomycin [8]. Molec-
ular weight and homogeneity were conﬁrmed by mass spectrometry
on a Micromass Q-TOF Ultima GLOBAL mass spectrometer. The syn-
thesis of perylene-daptomycin has been described as well [9].
2.2. Preparation of PC/PG large unilamellar vesicles (LUV)
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA). Large
unilamellar vesicles were prepared by polycarbonate membrane
extrusion as described [8]. HEPES buffer (20 mM, pH 7.4) containing
150 mM sodium chloride was used throughout.
2.3. Isothermal titration calorimetry (ITC)
Binding of daptomycin, of CB-182,462, and of a 1/1 (mol) mixture
of the two to lipid vesicles was measured calorimetrically at 25 °C
using a VP-ITC from Microcal (GE Healthcare, Northampton, MA).
LUV for this assay were prepared from equimolar dioleoyl-PG (DOPG)and dioleoyl-PC (DOPC) (5 mM total lipid) in buffer (10 mM HEPES,
100 mM sodium chloride, 1 mM CaCl2 pH 7.4) by the freeze–thaw/
extrusion method. Lipopeptides were dissolved in the same buffer.
In a typical ITC experiment, the sample cell was ﬁlled with 23 μM
lipopeptide solution and the reference cell with buffer. The 250 μl
titration syringe was loaded with LUV suspension. Solutions and
suspensions were degassed with stirring for 10 min prior to titra-
tions. After system equilibration and a stable baseline was achieved,
a 1 μl aliquot of LUV suspension was injected, the heat signal of
which was excluded from data analysis according to the instrument's
manufacturer's recommendation, followed by 2.5 μl injections at
6 min intervals until several successive injections generated low
and constant heat signals. The cell contents were stirred by the injec-
tion syringe throughout the titration at a rate of 270 rpm. Heat
resulting from LUV dilution into buffer, which was small and constant
(data not shown), was subtracted, and the baseline was adjusted
manually to the average noise value prior to data analysis [13]. Data
were collected and analyzed using proprietary Origin software pro-
vided by Microcal. Thermodynamic parameters were derived from
least squares analysis of the integrated heat signals using Origin's
one-site model curve ﬁtting routine. Experiments were performed
at least in triplicate and derived parameters were reproducible within
15%.
2.4. Steady-state ﬂuorescence measurements on PC/PG liposomes and on
bacterial cells
Fluorescence emission spectra were acquired using a PTI
QuantaMaster spectroﬂuorometer. Excitation wavelengths were
282 nm for tryptophan, 430 nm for perylene, and 465 nm for di-
rectly excited NBD ﬂuorescence. Excitation and emission band passes










































Fig. 2. Formation of CB-182,462 oligomers on PC/PG liposomes. NBD-labeled CB-182,462
(0.96 μM) and unlabeled CB-182,462 (4.8 μM), alone or combination, were incubated
with PC/PG (1:1, 200 μM total lipid) liposomes in the presence of calcium (5 mM).
A: Tryptophan ﬂuorescence upon excitation at 282 nm. NBD-CB-182,462 has virtually
none, due to FRET from tryptophan to NBD. When the two compounds are mixed before
application to liposomes, the tryptophan ﬂuorescence is more strongly quenched than
when they are applied separatelywith a time interval of 5 min between both applications.
This is consistent with the formation of hybrid oligomers in the ﬁrst case but mostly
segregated oligomers in the second. The emission of NBD was not scanned in this exper-
iment because it overlaps the secondary maximum of the excitation wavelength.
B: Self-quenching of NBD-CB-182,462. Addition of unlabeled CB-182,462 before applica-
tion to the PC/PG liposomes increases the ﬂuorescence intensity of NBD-CB-182,462
upon direct excitation of NBD at 465 nm, indicating that the latter is subject to self-
quenching in homogeneous oligomers. If the unlabeled CB-182,462 is added 5 min after
the NBD-labeled sample, it has little effect on the extent of quenching.
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labeled CB-182,462 and perylene-labeled daptomycin were applied in
the quantities indicated in the Results section to the liposomes (200
or 250 μM total lipid) in HEPES/NaCl with calcium (5 mM). Samples
were incubated for 5 or 10 min before acquisition of emission spectra,
and in some instances measured repeatedly after longer time intervals
as indicated.
For ﬂuorescence measurements on bacteria, cells from a fresh
overnight culture of Bacillus subtilis ATCC 1046 were harvested and
repeatedly washed with HEPES/NaCl buffer by centrifugation in a
table-top centrifuge. The pelleted cells were resuspended in approxi-
mately 20 volumes of buffer. Of the resulting cell suspension, 150 μl
were incubated in the presence of CaCl2 (5 mM) for 10 min with
the amounts of labeled or unlabeled daptomycin and CB-182,462
stated in the Results section. The cells were again washed repeatedly
by centrifugation with HEPES/NaCl/CaCl2, resuspended in the same
buffer and measured as described above for liposome samples.
2.5. Antibacterial activity of daptomycin and CB-182,462
Overnight cultures of Bacillus subtilis ATCC 1046 were grown at
37 °C in LB broth. Daptomycin and CB-182,462, alone or combined in
various ratios, were serially diluted in LB broth supplemented with
5 mM CaCl2 (the mixing ratios and dilutions are depicted in Fig. 6 in
the Results section). Each serial dilution was inoculated with 1% by vol-
ume of the Bacillus subtilis overnight culture, and the culture tubeswere
incubatedwith shaking at 37 °C overnight. Growth was evaluated visu-
ally by turbidity. The transition from translucency (that is, inhibition) to
high turbidity (growth) usually occurred abruptly. When intermediate
turbidity was observed, which occurred at the most once in any given
dilution series, the concentration in question was considered not
inhibitory; that is, the minimum inhibitory concentration (MIC) was
taken to be the lowest concentration without any visible turbidity.
Growth and sterility controls were included in each experiment.
3. Results
3.1. Oligomerization of CB-182,462 on liposome membranes
We have previously shown that daptomycin forms oligomers on
model membranes and bacterial cells [8,9,14]. While the similarity
between the two compounds suggests that CB-182,462 should do
the same, this has not been directly demonstrated. Therefore, a ﬂuo-
rescently labeled derivative was prepared with nitrobenzoxadiazole
(NBD) attached to its unique free amino group (Fig. 1). While the
absorption of NBD is highest around 470 nm, there is a smaller
absorption peak around 340 nm [15] that overlaps the ﬂuorescence
emission spectrum of tryptophan. This allows the detection of FRET
between the tryptophan of unlabeled CB-182,462 and the NBD-
labeled derivative. In the experiment shown in Fig. 2A, the two
species were mixed before application to PC/PG liposomes in the
presence of calcium. The tryptophan ﬂuorescence of the unlabeled
molecules is very strongly reduced by FRET, which indicates a close
association of the two species. FRET is still observed, but to a lesser
extent, when the two species are applied sequentially. Under these
conditions, the labeled molecules and the unlabeled ones should
undergo oligomerization separately, and therefore FRET will only
occur between, but not within oligomers, which accounts for the
reduced extent of FRET.
NBD exhibits concentration-dependent self-quenching [16]. The
local concentration of NBD is higher, and therefore quenching is
more pronounced, in pure NBD-CB-182,462 oligomers than in hybrid
oligomers formed from a mixture of the NBD-labeled compound and
an excess of the unlabeled one (Fig. 2B). The results from both FRET
and self-quenching experiments are completely analogous to our
previous observations with daptomycin [8].3.2. Formation of daptomycin/CB-182,462 hybrid oligomers on liposomes
The intrinsic ﬂuorescence of tryptophan also overlaps the absorp-
tion spectrum of kynurenine, which in daptomycin causes virtually
complete FRET from tryptophan to kynurenine [17]. FRET between
tryptophan and kynurenine can also be used to detect formation of
hybrid CB-182,462/daptomycin oligomers. When a premixed sample
of the two is applied to PC/PG liposomes, the tryptophan ﬂuorescence
of CB-182,462 is largely suppressed by FRET (Fig. 3A). Again, sequen-
tial application reduces FRET, which is consistent with formation of
separate oligomers.
While daptomycin oligomers are largely stable on a time scale of
one or a few hours [8], it seems possible that hybrid oligomers
of CB-182,462 might be less stable. In the experiment shown in
Fig. 3B, a sample prepared by sequential application of the two antibi-
otics was incubated, and the ﬂuorescence emission measured repeat-
edly after various time intervals. While the extent of FRET increases
slightly with time, it remains much lower than that observed with a
premixed sample after 60 min. This suggests that the rate of subunit
exchange between oligomers is low, and oligomers are largely stable
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Fig. 3. Formation of hybrid oligomers of native CB-182,462 and daptomycin on liposomes.
A: When both compounds (2 μM each) are mixed before addition to PC/PG liposomes
(250 μM total lipid) and calcium (5 mM), the tryptophan ﬂuorescence of CB-182,462 is
strongly reduced by FRET, and the kynurenine emission of daptomycin (around
445 nm) is increased. The extent of FRET is smaller when one compound is applied to
the liposomes 5 min after the ﬁrst one. B: Extended incubation of a sequentially prepared
sample. The extent of FRET increases slightly with time, but after 60 min still does not
approach that of a premixed sample, indicating that daptomycin and CB-182,462 mostly
do not reassemble into hybrid oligomers within this time period. Thin dotted lines
represent several time points between 5 and 60 min.
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Fig. 4 shows the ITC traces of daptomycin alone (A), CB-182,462
alone (C) and of an equimolar mixture (B) titrated with liposomesA B C
Fig. 4. Interaction of homogeneous and hybrid oligomers with DOPC/DOPG membranes, s
corresponding integrated isotherms (bottom panels) for titrations of pure daptomycin (A
(mol/mol) PG/PC liposomes at 25 °C. Solid lines are best-ﬁt curves obtained with Microcal's
All experiments were performed at least in triplicate and results were reproducible withinprepared from an equimolar mixture of DOPC and DOPG. In all
cases, early injections result in exothermic heat signals, which gradu-
ally decrease to very low spikes that represent heat of LUV dilution.
Integration of the heat signals from these experiments produce the
sigmoid curves typical for ITC experiments in which binding between
membrane and drugs is speciﬁc and saturable. The titration proﬁles
and the calculated energy terms for ΔH, TΔS and ΔG (Fig. 4D) are
quite similar between the pure daptomycin and CB-182,462 samples
on the one hand and the equimolar mixture on the other, which
supports the notion that the hybrid oligomers resemble the pure
ones with respect to thermodynamic stability.
Another interesting aspect of the ITC results is the observed
stoichiometry of the lipopeptides and phosphatidylglycerol, which is
very close to 2 molecules of PG for each molecule of antibiotic. In a
previous study using perylene excimer ﬂuorescence and lipid bicelles,
we observed a stoichiometry of 1 [9]. One possible explanation for the
discrepancy is that, in the liposome system, the lipopeptides interact
only with the outer monolayer. Alternatively, it is possible that
excimer ﬂuorescence and thermal changes report on different stages
of the membrane interaction that require only one and twomolecules
of PG, respectively. This question requires further study.
3.3. Formation of hybrid oligomers on bacterial cells
While PC/PG membranes are a useful model to observe the
activity of daptomycin and CB-182,462, the lipid composition of
bacterial membranes is different, and it is therefore pertinent to
examine the formation of hybrid oligomers on bacterial cells as
well. Due to the abundance of tryptophan in bacterial proteins, the
intrinsic tryptophan ﬂuorescence of CB-182,462 could not be used
in these experiments; however, two alternative approaches allowed
for the detection of hybrid oligomers on Bacillus subtilis cells. Firstly,
the concentration-dependent self-quenching of NBD in NBD-labeled
CB-182,462 can be inhibited not only by unlabeled CB-182,462 but
also using unlabeled daptomycin (Fig. 5A). Secondly, the formation
of perylene excimers in oligomers of perylene-labeled daptomycin
[9] is suppressed by both unlabeled daptomycin and unlabeled
CB-182,462 (Fig. 5B). Between the two experiments, it is evident
that both the labeled and the unlabeled forms of daptomycin and
CB-182,462 are capable of hybrid oligomer formation on bacterial
cell membranes.D
tudied with isothermal calorimetry (ITC). A–C: Raw ITC heat signals (top panels) and
), equimolar daptomycin/CB-182,462 hybrids (B), and pure CB-182,462 (C) with 1/1
Origin single binding site model. D: Summary of thermodynamic binding parameters.
















































Fig. 5. Formation of hybrid CB-182,462 oligomers on Bacillus subtilis cell membranes.
A: Alleviation of NBD-CB-182,462 self-quenching by unlabeled CB-182,462 or
daptomycin. NBD-CB-182,462 (4 μM), alone or premixed with unlabeled CB-182,462 or
daptomycin (20 μM), was incubated with Bacillus subtilis ATCC 1046 cells in the presence
of calcium (5 mM). After incubation for 10 min, the cells werewashed repeatedly by cen-
trifugation, re-suspended inbuffer, and theNBDﬂuorescencemeasuredupon excitation at
465 nm. B: Inhibition of excimer formation by perylene-daptomycin by unlabeled
daptomycin or CB-182,462. Perylene-daptomycin monomers emit maximally at 455 nm,
whereas the excimers emit maximally at about 525 nm [9]. Concentrations of labeled










































CB-182,462 / daptomycin (mol / mol)
Fig. 6. Mutual inhibition of bactericidal action between daptomycin and CB-182,462.
A: Isobologram of MICs observed in an individual experiment. Daptomycin and
CB-182,462 were admixed in LB medium and serially diluted at the ratios indicated;
thin solid lines connect serial dilutions of the same starting mixture. Bacillus subtilis
ATCC 1046 was pre-grown in LB broth and inoculated 1:100 into each serial dilution.
In case of independent and additive action, all MICs should fall on a straight line
connecting those of the pure antibiotics. The observed MICs of the mixtures deviate
toward higher concentrations, indicating mutual inhibition. B: The ratio of the observed
MIC to the hypothetical MIC expected from the linear additivity relation was calculated
for each of the indicated mixing ratios. Data represent averages and standard deviations
from six independent experiments. Higher ratios indicate greater mutual inhibition.
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If two different drugs act independently but share the same target
and mode of action, their mixtures will display additive effectiveness.
This can be detected in an isobologram [18]. In such a graph, the con-
centrations of the two drugs in question are varied independently,
and lines are drawn to connect equieffective dosages of various com-
binations. If the two drugs in question indeed behave additively, the
equieffective dosages of all mixtures will fall on a straight line that
connects the equieffective dosages of the two pure drugs.
Fig. 6A shows an isobologram for the minimum inhibitory concen-
trations (MICs) of daptomycin and CB-182,462. It is clear that the
observed MICs deviate from such an ideal straight line. With the
mixtures, greater than additive dosages are required to reach the
MIC, indicating that the two drugs inhibit one another. The discrepan-
cy is greatest with the equimolar mixture of the two antibiotics,
indicating that mutual inhibition is most pronounced at this ratio
(Fig. 6B). While any binary mixture should produce a distribution
of oligomers that vary with respect to both the fractions of the
two antibiotics incorporated and the positions within the oligomer
occupied by each, an equimolar ratio should maximize the extent of
scrambling and minimize the residual fractions of homogeneous
oligomers. The observation that mutual inhibition is strongest at
this ratio therefore supports the notion that hybrid oligomers have
impaired antibacterial activity.4. Discussion
In previous studies, it was shown that daptomycin forms oligomers
on PG-containing membranes [8,9], and that the oligomers have a stoi-
chiometry of approximately 6–7 subunits, or possibly twice that num-
ber [14]. A role of membrane-associated oligomers in the antibacterial
activity of daptomycin has widely been assumed and accepted as
plausible [5]; however, direct experimental evidence has been lacking.
The mutual inhibition between daptomycin and the semisynthetic
homologous lipopeptide CB-182,462 reported in this study constitutes
the ﬁrst such evidence; for if each individual monomer contributed
independently and proportionally to the antibacterial action, combina-
tions of the two antibiotics should display strictly additive activity.
Considering the number of subunits (at least 6) and the efﬁciency
of FRET between the two antibiotics (Fig. 2A), it is likely that the
oligomers produced by equimolar mixtures are indeed mostly
hybrids, albeit with varying subunit stoichiometry. According to ITC,
these oligomers have virtually the same stability as the homogeneous
ones, which suggests that hybrid and homogeneous oligomers are
also structurally similar. This is supported by the observation that
equimolar mixtures exhibit only moderately reduced antibacterial
activity, which means that some of the hybrids formed by this
mixture are functionally active. Conceivably, the ones that are not
active resemble a “pre-pore” stage that may also transiently exist
with homogeneous oligomers, and which has to undergo an addition-







Fig. 7. Hypothetical model for daptomycin action. A: Membrane binding (1) precedes
oligomerization (2), which in turn must be followed by membrane insertion (3) in order
to produce functional membrane lesions. B: In mixtures of daptomycin and CB-182,462
(bottom), oligomerization is preserved, but membrane insertion and permeabilization
may be disrupted.
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Staphylococcus aureus α-toxin [19,20], anthrax toxin protective antigen
[21] and the cholesterol-dependent cytolysins of Gram-positive bacteria
[22], all of which ﬁrst assemble into oligomers atop the target membrane
before cooperatively inserting into and permeabilizing it. However, this
hypothetical scenario, which is depicted in Fig. 7, clearly needs to
be addressed by further experimental study; it is not known at this
time whether or not the inactive hybrid oligomers resemble a kinetic
intermediate of the normal, active membrane lesion. The need for
further experiments also pertains to the functional roles of individu-
al amino acid residues in the daptomycin molecule. While our study
makes an initial distinction between two functional groups of
residues — namely, the ones shared between daptomycin and
CB-182,462, which sufﬁce for oligomerization, and those not shared
between the two molecules, which make at least some contribution
to oligomer activation— this level of resolution is clearly inadequate for
construction of a detailed structural and functional model of the forma-
tion and activation of the oligomer. Studies with additional synthetic or
genetically engineered [23,24] molecular variants of daptomycin may
help to address this question.
The high degree of speciﬁcity in the mutual interaction of the
subunits within the daptomycin and CB-182,462 oligomers agrees
with the considerable stability of the oligomers; even the hybrids,
which one might expect to be less stable than the homogeneous
oligomers, appear mostly stable on a time scale longer than required
for exercising the antibacterial effect.
Daptomycin has been likened to the large and structurally diverse
functional family of antibacterial peptides [25,26]. However, with
most antibacterial peptides, oligomer formation seems to be rather
ﬂeeting and transient, or at least more readily reversible [27–30] than
with daptomycin and CB-182,462. It appears possible, therefore, that
pore-forming protein toxins provide a more useful and valid paradigm
than typical antimicrobial peptides to understand daptomycin's mode
of action.Acknowledgement
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